| A combinatorial bidirectional and bicistronic approach for coordinated multi-gene expression in corn S Kumar, D AlAbed, JT Whitteck, W Chen, S Bennett, A Asberry, X Wang, ... Plant molecular biology 87, 341-353, 2015 | 32 | 2015 |
| PRMT5: a putative oncogene and therapeutic target in prostate cancer E Beketova, JL Owens, AM Asberry, CD Hu Cancer gene therapy 29 (3), 264-276, 2022 | 30 | 2022 |
| PRMT5 cooperates with pICln to function as a master epigenetic activator of DNA double-strand break repair genes JL Owens, E Beketova, S Liu, SL Tinsley, AM Asberry, X Deng, J Huang, ... Iscience 23 (1), 2020 | 29 | 2020 |
| Protein arginine methyltransferase 5 promotes pICln-dependent androgen receptor transcription in castration-resistant prostate cancer E Beketova, S Fang, JL Owens, S Liu, X Chen, Q Zhang, AM Asberry, ... Cancer research 80 (22), 4904-4917, 2020 | 23 | 2020 |
| Targeting protein arginine methyltransferase 5 suppresses radiation-induced neuroendocrine differentiation and sensitizes prostate cancer cells to radiation JL Owens, E Beketova, S Liu, Q Shen, JS Pawar, AM Asberry, J Yang, ... Molecular cancer therapeutics 21 (3), 448-459, 2022 | 12 | 2022 |
| Discovery and biological characterization of PRMT5: MEP50 protein–protein interaction inhibitors AM Asberry, X Cai, X Deng, U Santiago, S Liu, HS Sims, W Liang, X Xu, ... Journal of medicinal chemistry 65 (20), 13793-13812, 2022 | 7 | 2022 |
| Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiation AM Asberry, S Liu, HS Nam, X Deng, J Wan, CD Hu Computational and Structural Biotechnology Journal 20, 5873-5885, 2022 | 6 | 2022 |
| Plant promoter for transgene expression S Kumar, P Barone, D Hemingway, E Etchison, A Asberry, H Pence, ... US Patent 10,457,955, 2019 | 6 | 2019 |
| Constructs for expressing transgenes using regulatory elements from setaria ubiquitin genes S Kumar, A Asberry US Patent 9,758,789, 2017 | 4 | 2017 |
| Root-preferred promoter from a brachypodium distachyon metallothionein-like gene S Kumar, D Hemingway, C Ausmus, AF Worden, A Asberry US Patent 9,914,933, 2018 | 2 | 2018 |
| Root-preferred promoter from a Panicum virgatum metallothionein-like gene S Kumar, D Hemingway, C Ausmus, AF Worden, A Asberry US Patent 9,914,934, 2018 | 2 | 2018 |
| Plant promoter for transgene expression S Kumar, D Hemingway, C Ausmus, AF Worden, A Asberry US Patent App. 15/097,349, 2016 | 1 | 2016 |
| Reconstruction of site specific nuclease binding sites DR Corbin, W Chen, S Novak, RM Lee, S Kumar, A Asberry, AF Worden US Patent App. 18/179,798, 2023 | | 2023 |
| Reconstruction of site specific nuclease binding sites DR Corbin, W Chen, S Novak, RM Lee, S Kumar, A Asberry, AF Worden US Patent 11,634,721, 2023 | | 2023 |
| Mechanism and Targeting of PRMT5: MEP50 in Therapy-Induced Neuroendocrine Differentiation in Prostate Cancer AM Asberry Purdue University Graduate School, 2022 | | 2022 |
| Plant pathogenesis-related protein promoter for transgene expression S Kumar, A Asberry, P Barone, R Sarria, S Foulk, N Sardesai US Patent App. 16/763,385, 2020 | | 2020 |
| Plant promoter from Panicum virgatum S Kumar, P Barone, D Hemingway, E Etchison, A Asberry, H Pence, ... US Patent 10,519,459, 2019 | | 2019 |
| Root-preferred promoter from a Panicum virgatum metallothionein-like gene S Kumar, D Hemingway, C Ausmus, AF Worden, A Asberry US Patent 10,450,577, 2019 | | 2019 |
| Root-preferred promoter from a brachypodium distachyon metallothionein-like gene S Kumar, D Hemingway, C Ausmus, AF Worden, A Asberry US Patent 10,443,067, 2019 | | 2019 |
| Plant promoter for transgene expression S Kumar, P Barone, D Hemingway, E Etchison, A Asberry, H Pence, ... US Patent 10,400,246, 2019 | | 2019 |
